SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-010631
Filing Date
2015-11-12
Accepted
2015-11-12 17:01:37
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbyl-10q_20150930.htm 10-Q 1542896
2 EX-31.1 cbyl-ex311_6.htm EX-31.1 10303
3 EX-31.2 cbyl-ex312_8.htm EX-31.2 9544
4 EX-32.1 cbyl-ex321_7.htm EX-32.1 8428
  Complete submission text file 0001564590-15-010631.txt   5437581

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cbyl-20150930.xml EX-101.INS 982977
6 XBRL TAXONOMY EXTENSION SCHEMA cbyl-20150930.xsd EX-101.SCH 44767
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbyl-20150930_cal.xml EX-101.CAL 43261
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbyl-20150930_def.xml EX-101.DEF 177757
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbyl-20150930_lab.xml EX-101.LAB 345179
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbyl-20150930_pre.xml EX-101.PRE 281951
Mailing Address 3181 PORTER DRIVE PALO ALTO CA 94304
Business Address 3181 PORTER DRIVE PALO ALTO CA 94304 650-855-6777
Carbylan Therapeutics, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36830 | Film No.: 151225668
SIC: 2834 Pharmaceutical Preparations